The landscape of diabetes care is changing with the arrival of skin-applied GLP-1 therapy. These novel patches offer a likely simpler alternative to injections for individuals managing diabetes mellitus type 2 . These patches deliver a GLP-1 agonist directly through the dermis , avoiding the nece